By Professor Gail Matthews

Journal articles

Lundgren JD; Babiker AG; Sharma S; Grund B; Phillips AN; Matthews G; Kan VL; Aagaard B; Abo I; Alston B; Arenas-Pinto A; Avihingsanon A; Badal-Faesen S; Brites C; Carey C; Casseb J; Clarke A; Collins S; Corbelli GM; Dao S; Denning ET; Emery S; Eriobu N; Florence E; Furrer H; Fätkenheuer G; Gerstoft J; Gisslén M; Goodall K; Henry K; Horban A; Hoy J; Hudson F; Azwa RISR; Kedem E; Kelleher A; Kityo C; Klingman K; Rosa AL; Leturque N; Lifson AR; Losso M; Lutaakome J; Madero JS; Mallon P; Mansinho K; Filali KME; Molina J-M; Murray DD; Nagalingeswaran K; Nozza S; Ormaasen V; Paredes R; Peireira LC; Pillay S; Polizzotto MN; Raben D; Rieger A; Sanchez A; Schechter M; Sedlacek D; Staub T; Touloumi G; Turner M; Madruga JV; Vjecha M; Wolff M; Wood R; Zilmer K; Lane HC; Neaton JD; INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group , 2023, 'Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.', NEJM Evid, 2, http://dx.doi.org/10.1056/evidoa2200302

Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks ML; Law H; Danwilai T; Starr M; Munier CML; Christ D; Singh M; Croucher PI; Brilot-Turville F; Turville S; Phan TG; Dore GJ; Darley D; Cunningham P; Matthews GV; Kelleher AD; Zaunders JJ, 2022, 'High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.1032911

Marshall AD; Matthews GV, 2022, 'Simplifying hepatitis C care models: a crucial step towards hepatitis C elimination', The Lancet Gastroenterology and Hepatology, 7, pp. 1066 - 1068, http://dx.doi.org/10.1016/S2468-1253(22)00306-5

Carson JM; Dore GJ; Lloyd AR; Grebely J; Byrne M; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Matthews GV; Hajarizadeh B, 2022, 'Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study', Clinical Infectious Diseases, 75, pp. 1809 - 1819, http://dx.doi.org/10.1093/cid/ciac246

Amin J; Vaccher S; Templeton DJ; Bavinton B; Jin F; Zablotska I; Matthews G; Ogilvie E; Yeung B; Ooi C; Dharan N; Baker DA; Read P; Guy R; Grulich AE, 2022, 'Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus–Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings from the Expanded PrEP Implementation in Communities–New South Wales Prospective Implementation Study', Clinical Infectious Diseases, 75, pp. 1497 - 1502, http://dx.doi.org/10.1093/cid/ciac231

Marshall AD; Martinello M; Treloar C; Matthews GV, 2022, 'Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103828

Adhikari A; Abayasingam A; Rodrigo C; Agapiou D; Pandzic E; Brasher NA; Fernando BSM; Keoshkerian E; Li H; Kim HN; Lord M; Popovic G; Rawlinson W; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson SC; Grubor-Bauk B; Lloyd AR; Martinello M; Bull RA; Tedla N; Kaldor J; Dore G; Sorrell T; Bartlett A; Lemberg D; Di Girolamo N; Byrne M; Hammoud M; Sultan R; Konecny P; Matthews G; Shek D; Holdaway S; Mitsa-Kos K; How-Chow D; Lagunday R; Robinson S; Terrill L; Joshi N; Li Y; Gill S; Sevehon A, 2022, 'Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 Infection', Journal of Immunology, 209, pp. 1499 - 1512, http://dx.doi.org/10.4049/jimmunol.2200272

Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Stella AO; Kindinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Jean T; Foster CSP; Christ D; Hoppe AC; Munier ML; Darley D; Churchill M; Stark DJ; Matthews G; Rawlinson WD; Kelleher AD; Turville SG, 2022, 'SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', eBioMedicine, 84, http://dx.doi.org/10.1016/j.ebiom.2022.104270

Rogers AJ; Wentworth D; Phillips A; Shaw-Saliba K; Dewar RL; Aggarwal NR; Babiker AG; Chang W; Dharan NJ; Davey VJ; Higgs ES; Gerry N; Ginde AA; Hayanga JWA; Highbarger H; Highbarger JL; Jain MK; Kan V; Kim K; Lallemand P; Leshnower BG; Lutaakome JK; Matthews G; Mourad A; Mylonakis E; Natarajan V; Padilla ML; Pandit LM; Paredes R; Pett S; Ramachandruni S; Rehman MT; Sherman BT; Files DC; Brown SM; Matthay MA; Thompson BT; Neaton JD; Lane HC; Lundgren JD, 2022, 'The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19', Annals of Internal Medicine, 175, pp. 1401 - 1410, http://dx.doi.org/10.7326/M22-0924

Holland TL; Ginde AA; Paredes R; Murray TA; Engen N; Grandits G; Vekstein A; Ivey N; Mourad A; Sandkovsky U; Gottlieb RL; Berhe M; Jain MK; Marines-Price R; Agbor Agbor BT; Mateu L; España-Cueto S; Lladós G; Mylonakis E; Rogers R; Shehadeh F; Filbin MR; Hibbert KA; Kim K; Tran T; Morris PE; Cassity EP; Trautner B; Pandit LM; Knowlton KU; Leither L; Matthay MA; Rogers AJ; Drake W; Jones B; Poulakou G; Syrigos KN; Fernández-Cruz E; Natale MD; Almasri E; Balerdi-Sarasola L; Bhagani SR; Boyle KL; Casey JD; Chen P; Douin DJ; Files DC; Günthard HF; Hite RD; Hyzy RC; Khan A; Kibirige M; Kidega R; Kiweewa F; Jensen JU; Leshnower BG; Lutaakome JK; Manian P; Menon V; Morales-Rull JL; O'Mahony DS; Overcash JS; Ramachandruni S; Steingrub JS; Taha HS; Waters M; Young BE; Phillips AN; Murray DD; Jensen TO; Padilla ML; Sahner D; Shaw-Saliba K; Dewar RL; Teitelbaum M; Natarajan V; Rehman MT; Pett S; Hudson F; Touloumi G; Brown SM; Self WH; Chang CC; Sánchez A; Weintrob AC; Hatlen T; Grund B; Sharma S; Reilly CS; Garbes P; Esser MT; Templeton A; Babiker AG; Davey VJ; Gelijns AC; Higgs ES; Kan V; Matthews G; Thompson BT; Neaton JD, 2022, 'Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial', The Lancet Respiratory Medicine, 10, pp. 972 - 984, http://dx.doi.org/10.1016/S2213-2600(22)00215-6

Shah SHBU; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ, 2022, 'Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales', JHEP Reports, 4, http://dx.doi.org/10.1016/j.jhepr.2022.100552

Douin DJ; Siegel L; Grandits G; Phillips A; Aggarwal NR; Baker J; Brown SM; Chang CC; Goodman AL; Grund B; Higgs ES; Hough CL; Murray DD; Paredes R; Parmar M; Pett S; Polizzotto MN; Sandkovsky U; Self WH; Young BE; Babiker AG; Davey VJ; Kan V; Gelijns AC; Matthews G; Thompson BT; Lane HC; Neaton JD; Lundgren JD; Ginde AA; Meintjes GA; Armstrong W; Glidden D; Maldonado Y; Murray BE; Ray SC; Rolla VC; Saloojee H; Tsiatis AA; Volberding PA; Kimmelman J; Hunsberger S, 2022, 'Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery', American Journal of Respiratory and Critical Care Medicine, 206, pp. 730 - 739, http://dx.doi.org/10.1164/rccm.202112-2836OC

Mylonakis E, 2022, 'Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 A Randomized Controlled Trial', Annals of Internal Medicine, 175, pp. 1266 - 1274, http://dx.doi.org/10.7326/M22-1503

Bartlett SR; Verich A; Carson J; Hosseini-Hooshyar S; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Martinez M; Marks P; Dore GJ; Matthews GV; Applegate T; Martinello M; Hosseini Hooshyar S, 2022, 'Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort', Health Science Reports, 5, http://dx.doi.org/10.1002/hsr2.719

Hernández Cordero AI; Yang CX; Yang J; Li X; Horvath S; Shaipanich T; MacIsaac J; Lin D; McEwen L; Kobor MS; Guillemi S; Harris M; Lam W; Lam S; Obeidat M; Novak RM; Hudson F; Klinker H; Dharan N; Montaner J; Man SFP; Kunisaki K; Sin DD; Leung JM; Baker JV; Duprez D; Carr A; Hoy J; Dolan M; Telenti A; Grady C; Matthews G; Rockstroh J; Belloso WH; Kagan JM; Wright E; Brew B; Price RW; Robertson K; Cysique L; Connett JE; Niewoehner DE; Endpoint Review Committee ; Lifson A; Davey RT; Gatell JM; Pedersen C; Prineas R; Worley J, 2022, 'The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study', eBioMedicine, 83, http://dx.doi.org/10.1016/j.ebiom.2022.104206

Mylonakis E; Lutaakome J; Jain MK; Rogers AJ; Moltó J; Benet S; Mourad A; Files DC; Mugerwa H; Kityo C; Kiweewa F; Nalubega MG; Kitonsa J; Nabenkema E; Murray DD; Braun D; Kamel D; Higgs ES; Hatlen TJ; Kan VL; Sanchez A; Tierney J; Denner E; Wentworth D; Babiker AG; Davey VJ; Gelijns AC; Matthews GV; Thompson BT; Lane HC; Neaton JD; Lundgren JD, 2022, 'Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)', Med, 3, pp. 531 - 537, http://dx.doi.org/10.1016/j.medj.2022.07.003

Papot E; Jacoby S; Arlinda D; Avihingsanon A; Azwa I; Borok M; Brown D; Cisse M; Dao S; Eriobu N; Kaplan R; Karyana M; Kumarasamy N; Losso MH; Matthews GV; Perelis L; Perez-Casas C; Ruxrungtham K; Watkins M; Lane HC; Kelleher A; Law M; Polizzotto M, 2022, 'Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT', HIV Research & Clinical Practice, 23, pp. 37 - 46, http://dx.doi.org/10.1080/25787489.2022.2103572

Catlett B; Starr M; Machalek DA; Danwilai T; Palmer M; Kelly A; Kaldor J; Dore GJ; Darley D; Matthews G; Cunningham PH, 2022, 'Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection: SARS-CoV-2 detection from dried blood spots', Journal of Clinical Virology Plus, 2, http://dx.doi.org/10.1016/j.jcvp.2022.100093

Wheeler A; Valerio H; Cunningham EB; Martinello M; Barocas JA; Colledge-Frisby S; Treloar C; Amin J; Henderson C; Read P; Matthews GV; Dunlop AJ; Gorton C; Hayllar J; Alavi M; Murray C; Marks P; Silk D; Degenhardt L; Dore GJ; Grebely J, 2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, 237, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543

Carson JM; Hajarizadeh B; Hanson J; O'Beirne J; Iser D; Read P; Balcomb A; Davies J; Doyle JS; Yee J; Martinello M; Marks P; Matthews GV; Dore GJ; Post J; Batey R; Smart J; Dawson O; Hill S; Douglas M; Montebello M; Collie P; Hallinan R; Snelgar G; Baker D; Galhenage S; Soo TM; Bopage R; Faros J; Cooper L; Nelson R; Shaw D; Wilson M; Pratt W; Hinton S; Wade A; Van Gessel H; Davidson L; Dibdin M; Lucas M; Ahmad R; Smith D; Tan K; Roder C; Harney B; Holdaway S; Walsh J; Fox P; Mousavi R; Lam W; Dahal RP; Habel P; Gilliver R; Silins E; Ackerman J; Deacon R; Hall E; Everson A; Stewart J; Milner M; Ferguson C; Tate-Baker J; Bradshaw J; Duncan G; Baluran G; Watson B; Hey C; Hickey R; Orme C; Miczkova S, 2022, 'Retreatment for hepatitis C virus direct-acting antiviral therapy virological failure in primary and tertiary settings: The REACH-C cohort', Journal of Viral Hepatitis, 29, pp. 661 - 676, http://dx.doi.org/10.1111/jvh.13705

Weld ED; Astemborski J; Kirk GD; Sulkowski MS; Katz S; Rothman R; Solomon SS; Matthews GV; Hsieh YH; Verma M; Traverso G; Swindells S; Owen A; Feld J; Flexner C; Mehta SH; Thomas DL, 2022, 'Preferences of Persons with or at Risk for Hepatitis C for Long-Acting Treatments', Clinical Infectious Diseases, 75, pp. 3 - 10, http://dx.doi.org/10.1093/cid/ciab913

Hall SAL; Burns GS; Anagnostou D; Vogrin S; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll A; Strasser SI; Sievert W; Desmond PV; Ngu MC; Angus P; Sinclair M; Meredith C; Matthews G; Revill PA; Jackson K; Littlejohn M; Bowden D; Locarnini SA; Visvanathan K; Thompson A, 2022, 'Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels', Alimentary Pharmacology and Therapeutics, 56, pp. 310 - 320, http://dx.doi.org/10.1111/apt.16968

He WQ; Matthews GV; Liu B, 2022, 'Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults', Digestive Diseases and Sciences, 67, pp. 2600 - 2607, http://dx.doi.org/10.1007/s10620-021-07008-z

Aggarwal A; Stella AO; Walker G; Akerman A; Esneau C; Milogiannakis V; Burnett DL; McAllery S; Silva MR; Lu Y; Foster CSP; Brilot F; Pillay A; Van Hal S; Mathivanan V; Fichter C; Kindinger A; Hoppe AC; Munier ML; Amatayakul-Chantler S; Roth N; Coppola G; Symonds GP; Schofield P; Jackson J; Lenthall H; Henry JY; Mazigi O; Jäck HM; Davenport MP; Darley DR; Matthews GV; Khoury DS; Cromer D; Goodnow CC; Christ D; Robosa R; Starck DJ; Bartlett NW; Rawlinson WD; Kelleher AD; Turville SG, 2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, 7, pp. 896 - 908, http://dx.doi.org/10.1038/s41564-022-01135-7

Hosseini-Hooshyar S; Hajarizadeh B; Bajis S; Law M; Janjua NZ; Fierer DS; Chromy D; Rockstroh JK; Martin TCS; Ingiliz P; Hung CC; Dore GJ; Martinello M; Matthews GV, 2022, 'Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression', The Lancet HIV, 9, pp. e414 - e427, http://dx.doi.org/10.1016/S2352-3018(22)00077-7

Lubel JS; Strasser SI; Thompson AJ; Cowie BC; MacLachlan J; Allard NL; Holmes J; Kemp WW; Majumdar A; Iser D; Howell J; Matthews GV, 2022, 'Australian consensus recommendations for the management of hepatitis B', Medical Journal of Australia, 216, pp. 478 - 486, http://dx.doi.org/10.5694/mja2.51430

Harney BL; Sacks-Davis R; Van Santen DK; Traeger M; Wilkinson AL; Asselin J; El-Hayek C; Fairley CK; Roth N; Bloch M; Matthews G; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS; Bastian L; Bateson D; Bowden S; Boyd M; Callander D; Carter A; Cogle A; Costello J; Dimech W; Dittmer J; Ellard J; Franklin L; Kim J; Mcgill S; Nolan D; Patel P; Pendle S; Polkinghorne V; Nguyen L; Nguyen T; O'connor C; Reed P; Ryder N; Selvey C; Vickers T; Walker M; Watchirs-Smith L; West M, 2022, 'The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019', Clinical Infectious Diseases, 74, pp. 1804 - 1811, http://dx.doi.org/10.1093/cid/ciab720

Howe AYM; Rodrigo C; Cunningham EB; Douglas MW; Dietz J; Grebely J; Popping S; Sfalcin JA; Parczewski M; Sarrazin C; de Salazar A; Fuentes A; Sayan M; Quer J; Kjellin M; Kileng H; Mor O; Lennerstrand J; Fourati S; Di Maio VC; Chulanov V; Pawlotsky JM; Harrigan PR; Ceccherini-Silberstein F; Garcia F; Martinello M; Matthews G; Fernando FF; Esteban JI; Müllhaupt B; Wiesch JSZ; Buggisch P; Neumann-Haefelin C; Berg T; Berg CP; Schattenberg JM; Moreno C; Stauber R; Lloyd A; Dore G; Applegate T; Ignacio J; Garcia-Cehic D; Gregori J; Rodriguez-Frias F; Rando A; Gozlan Y; Angelico M; Andreoni M; Babudieri S; Bertoli A; Cento V; Coppola N; Craxì A; Paolucci S; Parruti G; Pasquazzi C; Perno CF; Teti E; Vironet C; Lannergård A; Duberg AS; Aleman S; Gutteberg T; Soulier A; Gourgeon A; Chevaliez S; Pol S; Carrat F; Salmon D; Kaiser R; Knopes E; Gomes P; de Kneght R; Rijnders B; Poljak M; Lunar M; Usubillaga R; Seguin_Devaux C; Tay E; Wilson C; Wang DS; George J; Kok J; Pérez AB; Chueca N; García-Deltoro M; Martínez-Sapiña AM; Lara-Pérez MM; García-Bujalance S; Aldámiz-Echevarría T; Vera-Méndez FJ; Pineda JA; Casado M; Pascasio JM; Salmerón J; Alados-Arboledas JC; Poyato A; Téllez F; Rivero-Juárez A, 2022, 'Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals', JHEP Reports, 4, pp. 100462, http://dx.doi.org/10.1016/j.jhepr.2022.100462

Harnpariphan W; Han WM; Supanun R; Ubolyam S; Sophonphan J; Ueaphongsukkit T; Gatechompol S; Tangkijvanich P; Thanprasertsuk S; Khwairakpam G; Ruxrungthan K; Phanuphak P; Matthews GV; Avihingsanon A, 2022, 'High Proportion of Blood-Borne and Sexually Transmitted Infections among People Deprived of Liberty in a Central Male Prison in Thailand: A Cross-Sectional Study 2018-2019', AIDS Research and Human Retroviruses, 38, pp. 370 - 377, http://dx.doi.org/10.1089/aid.2021.0134

Hosseini-Hooshyar S; Alavi M; Martinello M; Valerio H; Tillakeratne S; Matthews GV; Dore GJ, 2022, 'Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study', Journal of Viral Hepatitis, 29, pp. 271 - 279, http://dx.doi.org/10.1111/jvh.13658

Krishnan A; Ellenberger KA; Phetsouphanh C; Kelleher AP; Matthews GV; Darley DR; Holloway CJ, 2022, 'Myocardial fibrosis occurs in non-hospitalised patients with chronic symptoms after COVID-19', IJC Heart and Vasculature, 39, http://dx.doi.org/10.1016/j.ijcha.2022.100964

Yee J; Carson JM; Hajarizadeh B; Hanson J; O’Beirne J; Iser D; Read P; Balcomb A; Doyle JS; Davies J; Martinello M; Marks P; Dore GJ; Matthews GV; Hanson J; Marks P; Byrne M; Post J; Batey R; Smart J; Dawson O; Hill S; Douglas M; Montebello M; Collie P; Hallinan R; Snelgar G; Baker D; Galhenage S; Soo TM; Bopage R; Faros J; Cooper L; Nelson R; Shaw D; Davies J; Wilson M; Pratt W; Hinton S; Wade A; Van Gessel H; Davidson L; Dibdin M; Lucas M; Ahmad R; Smith D; Tan K; Roder C; Harney B; Holdaway S; Walsh J; Fox P; Mousavi R; Lam W; Dahal RP; Habel P; Gilliver R; Silins E; Ackerman J; Deacon R; Hall E; Everson A; Milner M; Ferguson C; Tate-Baker J; Bradshaw J; Duncan G; Baluran G; Watson B; Hey C; Hickey R; Orme C; Miczkova S, 2022, 'High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study', Hepatology Communications, 6, pp. 496 - 512, http://dx.doi.org/10.1002/hep4.1826

Phetsouphanh C; Darley DR; Wilson DB; Howe A; Munier CML; Patel SK; Juno JA; Burrell LM; Kent SJ; Dore GJ; Kelleher AD; Matthews GV, 2022, 'Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection', Nature Immunology, 23, pp. 210 - 216, http://dx.doi.org/10.1038/s41590-021-01113-x

Krishnan A; Ellenberger K; Chansavath P; Kelleher A; Matthews G; Darley D; Holloway C, 2022, 'Myocardial Fibrosis Occurs in Non-Hospitalised Patients With Chronic Symptoms After COVID-19', Heart, Lung and Circulation, 31, pp. S169 - S170, http://dx.doi.org/10.1016/j.hlc.2022.06.267

Fulford TS; Van H; Gherardin NA; Zheng S; Ciula M; Drummer HE; Redmond S; Tan HX; Boo I; Center RJ; Li F; Grimley SL; Wines BD; Nguyen THO; Mordant FL; Ellenberg P; Rowntree LC; Kedzierski L; Cheng AC; Doolan DL; Matthews G; Bond K; Hogarth PM; McQuilten Z; Subbarao K; Kedzierska K; Juno JA; Wheatley AK; Kent SJ; Williamson DA; Purcell DFJ; Anderson DA; Godfrey DI, 2021, 'A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2', EBioMedicine, 74, http://dx.doi.org/10.1016/j.ebiom.2021.103729

Valerio H; Alavi M; Law M; McManus H; Tillakeratne S; Bajis S; Martinello M; Matthews GV; Amin J; Janjua NZ; Krajden M; George J; Degenhardt L; Grebely J; Dore GJ, 2021, 'Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study', Clinical Infectious Diseases, 73, pp. 2037 - 2044, http://dx.doi.org/10.1093/cid/ciab526

Feld JJ; Matthews GV, 2021, 'Don't Wait: The Benefits of Early Diagnosis in Perinatal Hepatitis C Virus Transmission', Clinical Infectious Diseases, 73, pp. E3347 - E3348, http://dx.doi.org/10.1093/cid/ciaa942

Acheson LS; Siefried KJ; Clifford B; Murray E; Steele M; Clague L; Malone V; Roberts DM; Ferguson LJ; Matthews GV; Ezard N, 2021, 'One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review', International Journal of Infectious Diseases, 112, pp. 63 - 65, http://dx.doi.org/10.1016/j.ijid.2021.09.012

Matthews G, 2021, 'Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial', Clinical Infectious Diseases, http://dx.doi.org/10.1093/cid/ciaa1500

Stafford F; Dore GJ; Clackett S; Martinello M; Matthews GV; Grebely J; Balcomb AC; Hajarizadeh B, 2021, 'Prescribing of direct-acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment program', Medical Journal of Australia, 215, pp. 332 - 333, http://dx.doi.org/10.5694/mja2.51204

Carson JM; Hajarizadeh B; Hanson J; O'Beirne J; Iser D; Read P; Balcomb A; Davies J; Doyle JS; Yee J; Martinello M; Marks P; Dore GJ; Matthews GV, 2021, 'Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103422

Darley DR; Dore GJ; Byrne AL; Plit ML; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of sars-cov-2 at 8 months in a prospective cohort', ERJ Open Research, 7, http://dx.doi.org/10.1183/23120541.00384-2021

Doyle JS; Van Santen DK; Iser D; Sasadeusz J; O'Reilly M; Harney B; Traeger MW; Roney J; Cutts JC; Bowring AL; Winter R; Medland N; Fairley CK; Moore R; Tee BK; Asselin J; El-Hayek C; Hoy JF; Matthews GV; Prins M; Stoové MA; Hellard ME, 2021, 'Microelimination of Hepatitis C among People with Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial', Clinical Infectious Diseases, 73, pp. E2164 - E2172, http://dx.doi.org/10.1093/cid/ciaa1500

Matthews GV; Bhagani S; Van der Valk M; Rockstroh J; Feld JJ; Rauch A; Thurnheer C; Bruneau J; Kim A; Hellard M; Shaw D; Gane E; Nelson M; Ingiliz P; Applegate TL; Grebely J; Marks P; Martinello M; Petoumenos K; Dore GJ; Marks P; Feld J; Amjad S; Tu E; Tamaddoni M; Thurnheer MC; Gilleece Y; Fraser C; Moriggia A; Lutz T; Moon J; Read P; Ustianowski A; Cordes C; Sasadeusz J; Hull M; Braun D, 2021, 'Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection', Journal of Hepatology, 75, pp. 829 - 839, http://dx.doi.org/10.1016/j.jhep.2021.04.056

Bastard P; Gervais A; Voyer TL; Rosain J; Philippot Q; Manry J; Michailidis E; Hoffmann HH; Eto S; Garcia-Prat M; Bizien L; Parra-Martínez A; Yang R; Haljasmägi L; Migaud M; Särekannu K; Maslovskaja J; De Prost N; Tandjaoui-Lambiotte Y; Luyt CE; Amador-Borrero B; Gaudet A; Poissy J; Morel P; Richard P; Cognasse F; Troya J; Trouillet-Assant S; Belot A; Saker K; Garçon P; Rivière JG; Lagier JC; Gentile S; Rosen LB; Shaw E; Morio T; Tanaka J; Dalmau D; Tharaux PL; Sene D; Stepanian A; Megarbane B; Triantafyllia V; Fekkar A; Heath JR; Franco JL; Anaya JM; Solé-Violán J; Imberti L; Biondi A; Bonfanti P; Castagnoli R; Delmonte OM; Zhang Y; Snow AL; Holland SM; Biggs CM; Moncada-Vélez M; Arias AA; Lorenzo L; Boucherit S; Coulibaly B; Anglicheau D; Planas AM; Haerynck F; Duvlis S; Nussbaum RL; Ozcelik T; Keles S; Bousfiha AA; El Bakkouri J; Ramirez-Santana C; Paul S; Pan-Hammarström Q; Hammarström L; Dupont A; Kurolap A; Metz CN; Aiuti A; Casari G; Lampasona V; Ciceri F; Barreiros LA; Dominguez-Garrido E; Vidigal M; Zatz M; Van De Beek D; Sahanic S; Tancevski I; Stepanovskyy Y; Boyarchuk O; Nukui Y; Tsumura M; Vidaur L; Tangye SG; Burrel S; Duffy D; Quintana-Murci L; Klocperk A, 2021, 'Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths', Science Immunology, 6, http://dx.doi.org/10.1126/sciimmunol.abl4340

Asano T; Boisson B; Onodi F; Matuozzo D; Moncada-Velez M; Renkilaraj MRLM; Zhang P; Meertens L; Bolze A; Materna M; Korniotis S; Gervais A; Talouarn E; Bigio B; Seeleuthner Y; Bilguvar K; Zhang Y; Neehus AL; Ogishi M; Pelham SJ; Le Voyer T; Rosain J; Philippot Q; Soler-Palacín P; Colobran R; Martin-Nalda A; Rivière JG; Tandjaoui-Lambiotte Y; Chaïbi K; Shahrooei M; Darazam IA; Olyaei NA; Mansouri D; Hatipoğlu N; Palabiyik F; Novelli G; Novelli A; Casari G; Aiuti A; Carrera P; Bondesan S; Barzaghi F; Rovere-Querini P; Tresoldi C; Franco JL; Rojas J; Reyes LF; Bustos IG; Arias AA; Morelle G; Kyheng C; Troya J; Planas-Serra L; Schlüter A; Gut M; Pujol A; Allende LM; Rodriguez-Gallego C; Flores C; Cabrera-Marante O; Pleguezuelo DE; de Diego RP; Keles S; Aytekin G; Akcan OM; Bryceson YT; Bergman P; Brodin P; Smole D; Smith CIE; Norlin AC; Campbell TM; Covill LE; Hammarström L; Pan-Hammarström Q; Abolhassani H; Mane S; Marr N; Ata M; Al Ali F; Khan T; Spaan AN; Dalgard CL; Bonfanti P; Biondi A; Tubiana S; Burdet C; Nussbaum R; Kahn-Kirby A; Snow AL; Bustamante J; Puel A; Boisson-Dupuis S; Zhang SY; Béziat V; Lifton RP; Bastard P; Notarangelo LD; Abel L; Su HC, 2021, 'X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19', Science Immunology, 6, http://dx.doi.org/10.1126/sciimmunol.abl4348

Tea F; Stella AO; Aggarwal A; Darley DR; Pilli D; Vitale D; Merheb V; Lee FXZ; Cunningham P; Walker GJ; Fichter C; Brown DA; Rawlinson WD; Isaacs SR; Mathivanan V; Hoffmann M; Pöhlman S; Mazigi O; Christ D; Rockett RJ; Sintchenko V; Hoad VC; Irving DO; Dore GJ; Gosbell IB; Kelleher AD; Matthews GV; Brilot F; Turville SG, 2021, 'SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants', PLoS Medicine, 18, http://dx.doi.org/10.1371/journal.pmed.1003656

Liu B; Jayasundara D; Pye V; Dobbins T; Dore GJ; Matthews G; Kaldor J; Spokes P, 2021, 'Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia', The Lancet Regional Health - Western Pacific, 12, http://dx.doi.org/10.1016/j.lanwpc.2021.100193

Ohata PJ; Su Lwin HM; Han WM; Khwairakpam G; Tangkijvanich P; Matthews GV; Avihingsanon A, 2021, 'Elimination of hepatitis C among HIV-positive population in Asia: Old and new challenges', Future Virology, 16, pp. 407 - 417, http://dx.doi.org/10.2217/fvl-2021-0015

Marriott D; Beresford R; Mirdad F; Stark D; Glanville A; Chapman S; Harkness J; Dore GJ; Andresen D; Matthews GV, 2021, 'Concomitant Marked Decline in Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Respiratory Viruses among Symptomatic Patients Following Public Health Interventions in Australia: Data from St Vincent's Hospital and Associated Screening Clinics, Sydney, NSW', Clinical Infectious Diseases, 72, pp. E649 - E651, http://dx.doi.org/10.1093/cid/ciaa1256

Back to profile page